Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Schneck

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Blood|March 10, 2001
Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial librariesC La Rosa, R Krishnan, S Markel, et al.
The Journal of Experimental Medicine|May 23, 2001
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunityA R Hamad, A Srikrishnan, P Mirmonsef, et al.
Human Immunology|December 1, 1996
Expression of human recombinant beta 2-microglobulin by Aspergillus nidulans and its activityS M O'Herrin, S Kulkarni, W R Kenealy, et al.
The Journal of Experimental Medicine|November 1, 1994
Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surfaceB Catipović, G Talluri, J Oh, et al.
Biomaterials|December 13, 2016
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanomaA K Kosmides, R A Meyer, J W Hickey, et al.
The Journal of Experimental Medicine|October 23, 1997
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptorsS M O'Herrin, M S Lebowitz, J G Bieler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Antigen-specific blockade of T cells in vivo using dimeric MHC peptideS M O'Herrin, J E Slansky, Q Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
Oncogene|March 16, 1995
Abnormal B-cell function in HTLV-I-tax transgenic miceR S Peebles, C R Maliszewski, T A Sato, et al.
AIDS Research and Human Retroviruses|August 13, 1999
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccinesL M Carruth, T F Greten, C E Murray, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Blood|March 10, 2001
Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial librariesC La Rosa, R Krishnan, S Markel, et al.
The Journal of Experimental Medicine|May 23, 2001
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunityA R Hamad, A Srikrishnan, P Mirmonsef, et al.
Human Immunology|December 1, 1996
Expression of human recombinant beta 2-microglobulin by Aspergillus nidulans and its activityS M O'Herrin, S Kulkarni, W R Kenealy, et al.
The Journal of Experimental Medicine|November 1, 1994
Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surfaceB Catipović, G Talluri, J Oh, et al.
Biomaterials|December 13, 2016
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanomaA K Kosmides, R A Meyer, J W Hickey, et al.
The Journal of Experimental Medicine|October 23, 1997
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptorsS M O'Herrin, M S Lebowitz, J G Bieler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Antigen-specific blockade of T cells in vivo using dimeric MHC peptideS M O'Herrin, J E Slansky, Q Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
Oncogene|March 16, 1995
Abnormal B-cell function in HTLV-I-tax transgenic miceR S Peebles, C R Maliszewski, T A Sato, et al.
AIDS Research and Human Retroviruses|August 13, 1999
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccinesL M Carruth, T F Greten, C E Murray, et al.
Pageof 3